home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> biomedical companies   |   search    |   registration     |   modification  
 

registry of biomedical companies

 
  April 20, 2024
promoting the transfer of scientific know-how between industry and academia
 
 
Registry of biomedical companies:

[3] [A] [B] [C] [D] [E] [F] [G] [H] [I] [J] [K] [L] [M] [N] [O] [P] [Q] [R] [S] [T] [U] [V] [W] [X] [Y] [Z] 467 active entries

holding company for Biological Products & Vaccine "VACSERA"

51, Wezaret Al Zeraa, Agouza
Giza-Cairo, Egypt
Egypt

Phone: 002 02 37611111
Fax: 002 02 3748 31 98

E-Mail: This e-mail address is being protected from spam bots, you need JavaScript enabled to view it
Please notice: This entry hasn't been updated by the submitting company for more than 2 years. It could be possible that this company doesn't longer exists.

Description:

Outline of the Organization
- VACSERA, is a production center for Vaccines, Sera & Biological products.
- VACSERA main responsibilities is to serve the government & the trade sector requirements from Vaccines, Sera & Biological products, through local production & or importation.
- VACSERA is considered as one of the main research centers in Egypt & the Middle East Area in Vaccines, Sera & Biological products.
- VACSERA also export its product to 26 Countries.
Current manufacturing facilities:
OPV, BCG, DTP, DT, TT, Anti T.S., Alb., G-glob. & other blood components & fractions.
Future expansion:
Hepatitis B, Measles, Mencevax.
VACSERA management established a very clear Sop's to ensure that the organization objectives are achieved. The Organization's objectives are to achieve.
1. The overall supplies of government requirements of Vaccines, Sera & Biological products.
2. The overall supplies, production, importation & export targets of VACSERA.
3. The Transfer of Technology of vaccine production from multinational companies.
4. Bilateral agreements with International companies in production of vaccines & biological products.
5. The establishment of very professional & efficient network to ensure maximum distribution and market coverage.
6. The regular & Continuous Availability of Products.
7. The strong Relationship with different outlets in the market.
8. The Continuous coordination with principals & updating the systems to the International standards.
9. The clarity & Integrity in all Organization operations.
10. Clarity and transparency of objectives and Organization goals.
FOR ADDITIONAL INFORMATION PLEASE CONTACT US ON :
PHONE: 002 02 37611111 ext 1600
E-mail :  ceo@vacsera.com

Selected Categories:

Product Company   Service Company
Biopharma
- General
- Research
Biotech
- Agriculture
- General
- Research
Diagnostics
- General
- Medical

Last update of this entry: October 27, 2010

   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by companies 4.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995-2024 HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.